Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1972 1
1974 1
1978 2
2005 2
2018 1
2020 1
2021 2
2022 2
2023 1
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial.
Paller AS, Simpson EL, Siegfried EC, Cork MJ, Wollenberg A, Arkwright PD, Soong W, Gonzalez ME, Schneider LC, Sidbury R, Lockshin B, Meltzer S, Wang Z, Mannent LP, Amin N, Sun Y, Laws E, Akinlade B, Dillon M, Kosloski MP, Kamal MA, Dubost-Brama A, Patel N, Weinreich DM, Yancopoulos GD, O'Malley JT, Bansal A; participating investigators. Paller AS, et al. Lancet. 2022 Sep 17;400(10356):908-919. doi: 10.1016/S0140-6736(22)01539-2. Lancet. 2022. PMID: 36116481 Clinical Trial.
Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trial.
Simpson EL, Silverberg JI, Worm M, Honari G, Masuda K, Syguła E, Schuttelaar MLA, Mortensen E, Laws E, Akinlade B, Patel N, Maloney J, Paleczny H, Delevry D, Xiao J, Dubost-Brama A, Bansal A. Simpson EL, et al. Among authors: sygula e. J Am Acad Dermatol. 2024 Jun;90(6):1190-1199. doi: 10.1016/j.jaad.2023.12.066. Epub 2024 Feb 1. J Am Acad Dermatol. 2024. PMID: 38296199 Free article. Clinical Trial.
Simple Method for Apples' Bruise Area Prediction.
Słupska M, Syguła E, Komarnicki P, Szulczewski W, Stopa R. Słupska M, et al. Among authors: sygula e. Materials (Basel). 2021 Dec 25;15(1):139. doi: 10.3390/ma15010139. Materials (Basel). 2021. PMID: 35009289 Free PMC article.
The correlation between serum E-selectin levels and soluble interleukin-2 receptors with relation to disease activity in localized scleroderma.
Wodok-Wieczorek K, Salwowska N, Syguła E, Wodok A, Wcisło-Dziadecka D, Bebenek K, Bergler-Czop B, Brzezińska-Wcisło L. Wodok-Wieczorek K, et al. Among authors: sygula e. Postepy Dermatol Alergol. 2018 Dec;35(6):614-619. doi: 10.5114/ada.2018.77613. Epub 2018 Nov 13. Postepy Dermatol Alergol. 2018. PMID: 30618531 Free PMC article.
Pyoderma gangrenosum coexisting with acute myelogenous leukaemia.
Krauze E, Brzezińska-Wcisło L, Kamińska-Winciorek G, Wygledowska-Kania M, Sygula E. Krauze E, et al. Among authors: sygula e. J Eur Acad Dermatol Venereol. 2005 Sep;19(5):589-92. doi: 10.1111/j.1468-3083.2005.01202.x. J Eur Acad Dermatol Venereol. 2005. PMID: 16164714
16 results